Meta-analysis of docetaxel-based doublet versus docetaxel alone as second-line treatment for advanced non-small-cell lung cancer

Cancer Chemotherapy and Pharmacology

Volumn 69, Issue 1, 2012, Pages 99-106

  Qi, Wei Xiang ^a   Shen, Zan ^a   Yao, Yang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Docetaxel; Meta analysis; Non small cell lung cancer; Second line therapy

Indexed keywords

CARBOPLATIN; DOCETAXEL; GEMCITABINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; IRINOTECAN; NAVELBINE; VANDETANIB;

ADVANCED CANCER; ANEMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; FATIGUE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; META ANALYSIS; MONOTHERAPY; NAUSEA; NEUTROPENIA; OUTCOMES RESEARCH; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; HUMANS; LUNG NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL RATE; TAXOIDS; TREATMENT OUTCOME;

EID: 84856749277     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-011-1678-9     Document Type: Review

References (22)

1. R Peto ZM Chen J Boreham 1999 Tobacco-the growing epidemic Nat Med 5 15 17 9883828 10.1038/4691 1:CAS:528:DyaK1MXmtFKjsQ%3D%3D (Pubitemid 29050987)
2. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun 2009 Cancer statisktics, 2009 CA Cancer J Clin 59 225 249 19474385 10.3322/caac.20006
3. FA Shepherd 1993 Screening, diagnosis and staging of lung cancer Curr Opin Oncol 5 310 322 8384493 10.1097/00001622-199303000-00010 1:STN:280:DyaK3s3gvVWqtw%3D%3D (Pubitemid 23111775)
4. FA Shepherd J Dancey R Ramlau K Mattson R Gralla M O'Rourke N Levitan L Gressot M Vincent R Burkes S Coughlin Y Kim J Berille 2000 Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy J Clin Oncol 18 2095 2103 10811675 1:CAS:528:DC%2BD3cXktVyjsLc%3D (Pubitemid 30324363)
5. FV Fossella R DeVore RN Kerr K Mattson R Gralla M O'Rourke N Levitan L Gressot M Vincent R Burkes S Coughlin Y Kim J Berille 2000 Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens: the TAX 320 Non-Small Cell Lung Cancer Study Group J Clin Oncol 18 2354 2362 10856094 1:CAS:528:DC%2BD3cXkvFWrsLg%3D (Pubitemid 30415821)
6. J Dancey FA Shepherd RJ Gralla YS Kim 2004 Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective randomized phase III trial Lung Cancer 43 183 194 14739039 10.1016/j.lungcan.2003.09.001 (Pubitemid 38114747)
7. C Delbaldo S Michiels N Syz JC Soria T Le Chevalier JP Pignon 2004 Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis JAMA 292 470 484 15280345 10.1001/jama.292.4.470 1:CAS:528:DC%2BD2cXmtFOmsLo%3D (Pubitemid 38988956)
8. P Therasse SG Arbuck EA Eisenhauer J Wanders RS Kaplan L Rubinstein J Verweij M Van Glabbeke AT van Oosterom MC Christian SG Gwyther 2000 New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216 10655437 10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D
9. MK Parmar V Torri L Stewart 1998 Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 2815 2834 9921604 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID- SIM110>3.0.CO;2-8 1:STN:280:DyaK1M7itVWksA%3D%3D (Pubitemid 28562978)
10. E Zintzaras JP Ioannidis 2005 Heterogeneity testing in meta-analysis of genome searches Genet Epidemiol 28 123 137 15593093 10.1002/gepi.20048
11. S Yusuf R Peto DR Jones R Collins P Sleight 1985 Beta blockade during and after myocardial infarction: an overview of the randomized trials Prog Cardiovasc Dis 27 335 371 2858114 10.1016/S0033-0620(85)80003-7 1:STN:280:DyaL2M7ktFSitw%3D%3D (Pubitemid 15107153)
12. CB Begg M Mazumdar 1994 Operating characteristics of a rank correlation test for publication bias Biometrics 50 1088 1101 7786990 10.2307/2533446 1:STN:280:DyaK2Mzgs1GrtQ%3D%3D
13. D Moher B Pham A Jones DJ Cook AR Jadad M Moher P Tugwell TP Klassen 1998 Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352 609 613 9746022 10.1016/S0140-6736(98)01085-X 1:STN:280:DyaK1cvhslWjtg%3D%3D (Pubitemid 28380142)
14. RS Herbst Y Sun WE Eberhardt P Germonpré N Saijo C Zhou J Wang L Li F Kabbinavar Y Ichinose S Qin L Zhang B Biesma JV Heymach P Langmuir SJ Kennedy H Tada BE Johnson 2010 Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial Lancet Oncol 11 619 626 20570559 10.1016/S1470-2045(10)70132-7 1:CAS:528:DC%2BC3cXotVWqu78%3D
15. V Gebbia C Gridelli C Verusio L Frontini E Aitini B Daniele T Gamucci G Mancuso M Di Maio C Gallo F Perrone A Morabito 2009 Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients. The DISTAL-2 randomized trial Lung Cancer 63 251 258 18632181 10.1016/j.lungcan.2008.05.027
16. D Pectasides M Pectasides D Farmakis 2005 Comparison of docetaxel and docetaxel-irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial Ann Oncol 16 294 299 15668287 10.1093/annonc/mdi053 1:STN:280:DC%2BD2M%2FjvFyhtg%3D%3D (Pubitemid 40309313)
17. K Takeda S Negoro T Tamura Y Nishiwaki S Kudoh S Yokota K Matsui H Semba K Nakagawa Y Takada M Ando T Shibata N Saijo 2009 Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104) Ann Oncol 20 835 841 19164456 10.1093/annonc/mdn705 1:STN:280:DC%2BD1MzgvVyntg%3D%3D
18. AG Pallis S Agelaki A Agelidou I Varthalitis K Syrigos N Kentepozidis G Pavlakou A Kotsakis E Kontopodis V Georgoulias 2010 A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic non-small cell lung cancer BMC Cancer 10 633 21092076 10.1186/1471-2407-10-633 1:CAS:528: DC%2BC3cXhsV2qtrvI
19. JV Heymach BE Johnson D Prager E Csada J Roubec M Pesek I Spásová CP Belani I Bodrogi S Gadgeel SJ Kennedy J Hou RS Herbst 2007 Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer J Clin Oncol 25 4270 4277 17878479 10.1200/JCO.2006.10.5122 1:CAS:528:DC%2BD2sXhtFyis7jN (Pubitemid 47548567)
20. FM Wachters HJ Groen B Biesma FM Schramel PE Postmus JA Stigt EF Smit 2005 A randomized phase II trial of docetaxel vs. docetaxel and irinotecan in patients with stage IIIb-IV non-small-cell lung cancer who failed first-line treatment Br J Cancer 92 15 20 15597104 10.1038/sj.bjc.6602268 1:CAS:528:DC%2BD2MXhtFSjsrY%3D (Pubitemid 40188429)
21. Y Segawa K Kiura K Hotta N Takigawa M Tabata K Matsuo H Yoshioka H Hayashi H Kawai K Aoe T Maeda H Ueoka M Tanimoto 2010 A randomized phase II study of a combination of docetaxel and S-1 versus docetaxel monotherapy in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy: results of Okayama Lung Cancer Study Group (OLCSG) Trial 0503 J Thorac Oncol 5 1430 1434 20651615 10.1097/JTO.0b013e3181e3248e
22. M Di Maio P Chiodini V Georgoulias D Hatzidaki K Takeda FM Wachters V Gebbia EF Smit A Morabito C Gallo F Perrone C Gridelli 2009 Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer J Clin Oncol 27 1836 1843 19273711 10.1200/JCO.2008.17.5844 1:CAS:528:DC%2BD1MXltlSisLc%3D